JP2019501647A5 - - Google Patents

Info

Publication number

JP2019501647A5

JP2019501647A5 JP2018528669A JP2018528669A JP2019501647A5 JP 2019501647 A5 JP2019501647 A5 JP 2019501647A5 JP 2018528669 A JP2018528669 A JP 2018528669A JP 2018528669 A JP2018528669 A JP 2018528669A JP 2019501647 A5 JP2019501647 A5 JP 2019501647A5

Authority

JP

Japan

Prior art keywords

chimeric receptor

domain

variant

amino acid

sequence

Prior art date

2016-12-02

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108700010039 chimeric receptor Proteins 0.000 claims 56
• 235000001014 amino acid Nutrition 0.000 claims 25
• 229940024606 amino acid Drugs 0.000 claims 19
• 150000001413 amino acids Chemical class 0.000 claims 19
• 125000003275 alpha amino acid group Chemical group 0.000 claims 16
• 238000012986 modification Methods 0.000 claims 13
• 230000004048 modification Effects 0.000 claims 13
• 230000011664 signaling Effects 0.000 claims 11
• 239000000203 mixture Substances 0.000 claims 9
• 238000006467 substitution reaction Methods 0.000 claims 9
• 102220292761 rs576215366 Human genes 0.000 claims 8
• 108010033276 Peptide Fragments Proteins 0.000 claims 7
• 102000007079 Peptide Fragments Human genes 0.000 claims 7
• 230000000139 costimulatory effect Effects 0.000 claims 7
• 230000001086 cytosolic effect Effects 0.000 claims 7
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
• 125000000539 amino acid group Chemical group 0.000 claims 6
• 239000000427 antigen Substances 0.000 claims 6
• 102000036639 antigens Human genes 0.000 claims 6
• 108091007433 antigens Proteins 0.000 claims 6
• 210000004027 cell Anatomy 0.000 claims 6
• 201000010099 disease Diseases 0.000 claims 6
• 108020001756 ligand binding domains Proteins 0.000 claims 6
• 102220610001 Bestrophin-2_L34A_mutation Human genes 0.000 claims 4
• 230000001747 exhibiting effect Effects 0.000 claims 4
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 3
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 3
• 238000003780 insertion Methods 0.000 claims 3
• 230000037431 insertion Effects 0.000 claims 3
• 230000003834 intracellular effect Effects 0.000 claims 3
• 108020004707 nucleic acids Proteins 0.000 claims 3
• 150000007523 nucleic acids Chemical class 0.000 claims 3
• 102000039446 nucleic acids Human genes 0.000 claims 3
• 108020003175 receptors Proteins 0.000 claims 3
• 102000005962 receptors Human genes 0.000 claims 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 2
• 102220610000 Bestrophin-2_R31A_mutation Human genes 0.000 claims 2
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims 2
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 2
• 206010028980 Neoplasm Diseases 0.000 claims 2
• 108091008874 T cell receptors Proteins 0.000 claims 2
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims 2
• 229960001230 asparagine Drugs 0.000 claims 2
• 235000009582 asparagine Nutrition 0.000 claims 2
• 210000004899 c-terminal region Anatomy 0.000 claims 2
• 239000003814 drug Substances 0.000 claims 2
• 210000000265 leukocyte Anatomy 0.000 claims 2
• 108090000765 processed proteins & peptides Proteins 0.000 claims 2
• 102200082944 rs1135071 Human genes 0.000 claims 2
• 208000023275 Autoimmune disease Diseases 0.000 claims 1
• 208000035473 Communicable disease Diseases 0.000 claims 1
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
• 102220471762 Proteasome subunit alpha type-7_K28A_mutation Human genes 0.000 claims 1
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
• 210000001744 T-lymphocyte Anatomy 0.000 claims 1
• 230000003213 activating effect Effects 0.000 claims 1
• 230000004913 activation Effects 0.000 claims 1
• 235000004279 alanine Nutrition 0.000 claims 1
• 201000011510 cancer Diseases 0.000 claims 1
• 208000035475 disorder Diseases 0.000 claims 1
• 229940079593 drug Drugs 0.000 claims 1
• 239000012634 fragment Substances 0.000 claims 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
• 230000005847 immunogenicity Effects 0.000 claims 1
• 208000015181 infectious disease Diseases 0.000 claims 1
• 239000003446 ligand Substances 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 238000000034 method Methods 0.000 claims 1
• 102200112956 rs104893657 Human genes 0.000 claims 1
• 102200031779 rs3204853 Human genes 0.000 claims 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1